Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy

1981 ◽  
Vol 141 (11) ◽  
pp. 1441-1444 ◽  
Author(s):  
R. Monson
Keyword(s):  
Drug Therapy ◽  
Clinical Pharmacist ◽  
Outpatient Therapy ◽  
Clinical Pharmacists

scholarly journals Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study

2020 ◽  
Vol Volume 12 ◽  
pp. 71-83 ◽  
Author(s):  
Gosaye Mekonen Tefera ◽  
Ameha Zewudie Zeleke ◽  
Yitagesu Mamo Jima ◽  
Tsegaye Melaku Kebede
Keyword(s):  
Drug Therapy ◽  
Clinical Pharmacist ◽  
Interventional Study ◽  
Drug Therapy Problems

Can clinical pharmacists bridge a gap between medical oncologists and patients in resource-limited oncology settings? An experience in Nepal

2018 ◽  
Vol 25 (3) ◽  
pp. 765-768 ◽  
Author(s):  
Sunil Shrestha ◽  
Sudip Shrestha ◽  
Subish Palaian
Keyword(s):  
Patient Care ◽  
Clinical Pharmacist ◽  
Human Services ◽  
Care Team ◽  
Medical Oncologist ◽  
Clinical Pharmacists ◽  
Resource Limited ◽  
Medical Oncologists ◽  
The World

The clinical pharmacist's part is emerging as a key extension to the human services care team bringing about enhanced patient care in the world. The main objective of this article is to highlight the role of clinical pharmacist in an oncology setting of Nepal. An enrollment of clinical pharmacist in an oncology hospital or in oncology settings can work as a bridge between medical oncologist and patients.

scholarly journals Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review

2021 ◽  
pp. 41
Author(s):  
◽  
◽  
◽  
Keyword(s):  
Acute Pancreatitis ◽  
Clinical Review ◽  
Fluid Therapy ◽  
Clinical Pharmacist ◽  
Published Data ◽  
Extensive Literature ◽  
Drug Induced ◽  
Physician Visits ◽  
Clinical Pharmacists

Introduction: The role of the clinical pharmacist in the management of acute pancreatitis has not been researched extensively, and only a few published studies on the topic can be found. This clinical review presents all pertinent published data and serves as a guide for clinical pharmacists who participate in the management of patients with acute pancreatitis. Methods: An extensive literature search was conducted on PubMed from 1990 to 2021 to retrieve relevant studies focusing on the role of the clinical pharmacist in the treatment of acute pancreatitis. Results: An analysis of the medications that are associated with acute pancreatitis is presented, highlighting the responsibility of the pharmacist to conduct a thorough medication investigation in order to identify a possible drug-induced acute pancreatitis. Medical management of acute pancreatitis, mainly fluid therapy, is an area where a clinical pharmacist can appropriately intervene. Proper choice of fluid therapy and its rate, nutritional considerations, pain management and antibiotic use, are all important to consider for a successful treatment with minimal adverse effects. It is well documented in the literature that clinical pharmacists can decrease hospital costs. Discharge counseling performed by a clinical pharmacist has been shown to increase patient compliance and decrease both readmission rates and follow-up physician visits. Conclusion: The clinical pharmacist, as the primary drug expert, can identify medication-induced pancreatitis, diminish the use of unnecessary antibiotics, improve patient care and decrease the overall costs.

The Role of an Inpatient Hospice and Palliative Clinical Pharmacist in the Interdisciplinary Team

2021 ◽  
pp. 104990912110494
Author(s):  
Jetavia Jones Moody ◽  
Ivy O. Poon ◽  
Ursula K. Braun
Keyword(s):  
Palliative Care ◽  
Clinical Pharmacist ◽  
Care Setting ◽  
Care Service ◽  
Health Care Service ◽  
Interdisciplinary Team ◽  
National Registry ◽  
Clinical Pharmacists ◽  
Palliative Care Setting

Palliative care is a specialized health care service for individuals with serious illness at any stage and can be provided in any setting. Current national consensus developed by palliative care experts recommends the inclusion of pharmacists in an interdisciplinary team (IDT) to provide quality palliative care. However, national registry data report that less than 10% of inpatient palliative teams in the U.S. have a clinical pharmacist. Clinical pharmacists have an impactful role in palliative patients’ quality of life by optimizing symptom management, deprescribing, and providing education to the palliative care team as well as patients and their families. In this report, we review the current literature on the role of a palliative pharmacist in an inpatient palliative care setting and compare and contrast this with our own clinical practice, providing case examples about the role of a palliative clinical pharmacist in an interdisciplinary inpatient palliative care setting. Future strategies are needed to increase post-graduate specialized pharmacy residency training in palliative care as well as education on palliative and hospice care in pharmacy schools to support the role of clinical pharmacists in palliative care.

scholarly journals INNV-18. THE AVAILABILITY AND ROLE OF CLINICAL PHARMACISTS IN THE AMBULATORY NEURO-ONCOLOGY SETTING: AN INTERNATIONAL SURVEY

2019 ◽  
Vol 21 (Supplement_6) ◽  
pp. vi134-vi134
Author(s):  
Mallika Patel ◽  
Eric Lipp ◽  
Elizabeth Miller Patrick Healy ◽  
James Herndon ◽  
Katherine Peters
Keyword(s):  
Clinical Pharmacist ◽  
Guideline Development ◽  
Primary Brain Tumor ◽  
Ambulatory Setting ◽  
Oncology Patients ◽  
Team Members ◽  
Clinical Pharmacists ◽  
Patient Interaction ◽  
Academic Practices

Abstract BACKGROUND Outpatient clinics treating neuro-oncology patients are becoming more multidisciplinary. Utilization of all team members is critical for the holistic care of these complex patients. Specifically, the role of a clinical pharmacist in the ambulatory multidisciplinary clinic remains undefined and will likely evolve as more therapeutic options are developed to treat central nervous system malignancies. We queried the Society for Neuro-Oncology (SNO) membership about the availability of a clinical pharmacist in their ambulatory setting and, if present, the role of that clinical pharmacist. METHODS In an IRB exempt study, we surveyed the SNO community (targeting primarily clinicians) and analyzed responses to queries about clinical pharmacists in the ambulatory neuro-oncology setting. RESULTS Of the 65 SNO members who responded, 52 of these were clinical members. Of these 52 clinical members, the majority were physicians (88.5%, n=46). Of these 46 physicians, most were in academic practices (93.5%, n=43). Over half of the 52 clinical respondents (51.9%, n=27) reported that they saw ≥ 30 primary brain tumor patients a month, thus typifying busy clinical neuro-oncology ambulatory clinics. Despite having busy clinics, only 12 (28.6%) of the 42 providers with access to a clinical pharmacist reported that their clinical pharmacist was solely dedicated to neuro-oncology patients. For the respondents who had access to a clinical pharmacist, only 28 (66.7%) of those pharmacists had direct patient interaction in the clinic. The top three roles of the clinical pharmacist included medication review (81%, n=34), chemotherapy dosing and modifications (73.8%, n=31), and practice guideline development (61.9%, n=26), none of which are associated with direct patient interaction. CONCLUSIONS We found that while our surveyed population of SNO clinical members have demanding outpatient neuro-oncology practices, most do not have the support or expertise of dedicated neuro-oncology clinical pharmacists.

Describing the role of the hematology/oncology clinical pharmacist in health information technology

2020 ◽  
pp. 107815522090892
Author(s):  
Jennifer S Philippon ◽  
Carolyn L Kusoski ◽  
Julie M Kennerly-Shah ◽  
Janinah S Barreto
Keyword(s):  
Information Technology ◽  
Electronic Health Record ◽  
Patient Care ◽  
Health Information Technology ◽  
Health Information ◽  
Clinical Pharmacist ◽  
Health Record ◽  
Clinical Pharmacists ◽  
Electronic Health

Purpose To describe the role of hematology/oncology clinical pharmacists in health information technology as well as their perceptions of the impact of technology expansion on patient care. Methods A single-center, web-based survey was distributed to 30 hematology/oncology clinical pharmacists by email over the two-week-period of 24 September 2018 to 8 October 2018. The anonymous survey was composed of 19 questions, with varying formats including multiple choice, fill-in-the-blank, and rank order. Primary endpoints were quantification of time spent in the electronic health record and perceptions on how technology expansion has impacted the safety, quality, and efficiency of patient care. Results Twenty-seven hematology/oncology clinical pharmacists (90% response rate) completed the survey in its entirety. Respondents reported that they spend an average of 84.1% of their work day in the electronic health record. Based on a 40-h work week, clinical pharmacists indicated that they spend approximately 32.2 h each week performing direct patient care tasks in the electronic health record compared to 3.7 h on indirect patient care tasks. All respondents reported a greater utilization of technology over the last five years, and most respondents felt that patient care is safer, of better quality, and more efficient with technology expansion. The majority of respondents (81.5%) indicated that clinical pharmacists have the best understanding of the health information technology system, followed by generalist pharmacists and informatics pharmacists. Conclusion The hematology/oncology clinical pharmacist is well positioned to serve as a health information technology leader on the interdisciplinary healthcare team.

Sign in / Sign up

Export Citation Format

Share Document